​

Funding Round

Series A - ViaNautis

Series A - ViaNautis

Investment Firm

Overview

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

Announced Date

Nov 13, 2023

Closed on Date

Nov 14, 2023

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

BGF Ventures

BGF Ventures

BGF Ventures is a early_stage_venture firm.

4BIO Capital

4BIO Capital

4BIO Capital is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

Participant Investors

7

Investor Name
Participant InvestorUCB Ventures
Participant InvestorCystic Fibrosis Foundation
Participant Investor4BIO Capital
Participant InvestorBGF Ventures
Participant InvestorEli Lilly

Round Details and Background

ViaNautis raised $24558590 on 2023-11-13 in Series A

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 15, 2019
Seed Round - ViaNautis
3-undefined
Apr 20, 2021
Series A - ViaNautis
4-2.9M
Nov 13, 2023
Series A - ViaNautis
8-24.6M

Recent Activity

There is no recent news or activity for this profile.